Related Experiment Video

Updated: Jun 19, 2026

Development and Maintenance of a Preclinical Patient Derived Tumor Xenograft Model for the Investigation of Novel Anti-Cancer Therapies
09:29

Development and Maintenance of a Preclinical Patient Derived Tumor Xenograft Model for the Investigation of Novel Anti-Cancer Therapies

Published on: September 30, 2016

cIAP2 as a therapeutic target in colorectal cancer and other malignancies

Koh Miura1, Hideaki Karasawa, Iwao Sasaki

  • 1Tohoku University Graduate School of Medicine, Department of Surgery, 1-1 Seiryo-machi, Aoba-ku, Sendai, Miyagi 980-8574, Japan. k-miura@surg1.med.tohoku.ac.jp

Expert Opinion on Therapeutic Targets
|October 2, 2009
PubMed

Insights

Inhibitor of apoptosis proteins (IAPs), like cIAP2, are elevated in colorectal cancer, promoting drug resistance. Downregulating cIAP2 enhances apoptosis and 5-fluorouracil sensitivity, making IAPs promising therapeutic targets.

Area of Science:

  • Oncology
  • Molecular Biology
  • Cancer Therapeutics

Background:

  • Colorectal cancer is a leading global malignancy with limited curative options for metastatic disease.
  • Inhibition of apoptosis, partly via the inhibitor of apoptosis protein (IAP) family, contributes to cancer development and treatment resistance.
  • Elevated IAP expression is common in human cancers, identifying them as potential therapeutic targets.

Purpose of the Study:

  • To review the role of cIAP2 and other IAP molecules as therapeutic targets in malignancies, with a focus on colorectal cancer.
  • To summarize current knowledge on drug development targeting IAP molecules.
  • To provide an overview of future directions in IAP-targeted cancer therapy.

Main Methods:

  • Literature review of studies on IAPs, apoptosis, NF-kappaB signaling, and colorectal cancer.
  • Analysis of evidence linking IAP downregulation to enhanced apoptosis and drug sensitivity.
  • Inclusion of data from other malignancies to broaden the scope due to limited colorectal cancer-specific data.

Main Results:

  • Downregulation of cIAP2 enhances apoptosis via caspase 3/7 activation in colorectal cancer cells.
  • cIAP2 downregulation increases sensitivity to 5-fluorouracil (5-FU) in colorectal cancer cells.
  • IAPs are implicated in both anti-apoptotic pathways and NF-kappaB signal transduction.

Conclusions:

  • cIAP2 and other IAPs represent viable therapeutic targets for colorectal cancer and other malignancies.
  • Targeting IAPs offers a potential strategy to overcome drug resistance and improve treatment outcomes.
  • Further research and drug development are needed to fully exploit IAPs as anti-cancer targets.

More Related Videos

Automated Preparation of [68Ga]Ga-3BP-3940 on a Synthesis Module for PET Imaging of the Tumor Microenvironment10:33

Automated Preparation of [68Ga]Ga-3BP-3940 on a Synthesis Module for PET Imaging of the Tumor Microenvironment

Published on: April 25, 2025

Related Concept Videos

Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
Inhibition of Cdk Activity02:34

Inhibition of Cdk Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
Combination Therapies and Personalized Medicine02:50

Combination Therapies and Personalized Medicine

Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
Cancer-Critical Genes II: Tumor Suppressor Genes01:05

Cancer-Critical Genes II: Tumor Suppressor Genes

Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the daughter...